Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × Stage I Prostate Adenocarcinoma × pexidartinib × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Synovitis, Pigmented Villonodular 1 Stage I Prostate Adenocarcinoma 1 Solid Tumor 1 Pancreatic Neoplasms 1 Neoplasm Metastasis 1 Gastrointestinal Stromal Tumors 1 Colorectal Neoplasms 1 Advanced Solid Tumors 1

Interventions

pexidartinib 1 Radiotherapy 1 Radiation 1 Androgen Antagonists 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02472275 2020-10-06

PLX3397, Radiation Therapy, and Antihormone Therapy in Treating Patients With Intermediate- or High-Risk Prostate Cancer

Barbara Ann Karmanos Cancer Institute

Phase 1 Completed

Stage I Prostate Adenocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡